261 related articles for article (PubMed ID: 27901481)
21. Macrophages protect against loss of adipose tissue during cancer cachexia.
Erdem M; Möckel D; Jumpertz S; John C; Fragoulis A; Rudolph I; Wulfmeier J; Springer J; Horn H; Koch M; Lurje G; Lammers T; Olde Damink S; van der Kroft G; Gremse F; Cramer T
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1128-1142. PubMed ID: 31318182
[TBL] [Abstract][Full Text] [Related]
22. Control of food intake and muscle wasting in cachexia.
Amitani M; Asakawa A; Amitani H; Inui A
Int J Biochem Cell Biol; 2013 Oct; 45(10):2179-85. PubMed ID: 23911307
[TBL] [Abstract][Full Text] [Related]
23. Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?
Mueller TC; Bachmann J; Prokopchuk O; Friess H; Martignoni ME
BMC Cancer; 2016 Feb; 16():75. PubMed ID: 26856534
[TBL] [Abstract][Full Text] [Related]
24. TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia.
Greco SH; Tomkötter L; Vahle AK; Rokosh R; Avanzi A; Mahmood SK; Deutsch M; Alothman S; Alqunaibit D; Ochi A; Zambirinis C; Mohaimin T; Rendon M; Levie E; Pansari M; Torres-Hernandez A; Daley D; Barilla R; Pachter HL; Tippens D; Malik H; Boutajangout A; Wisniewski T; Miller G
PLoS One; 2015; 10(7):e0132786. PubMed ID: 26172047
[TBL] [Abstract][Full Text] [Related]
25. The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia.
Kasprzak A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557173
[TBL] [Abstract][Full Text] [Related]
26. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.
Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ
Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276
[TBL] [Abstract][Full Text] [Related]
27. Disrupted NOS2 metabolism drives myoblast response to wasting-associated cytokines.
Arneson-Wissink PC; Doles JD
Exp Cell Res; 2021 Oct; 407(1):112779. PubMed ID: 34428455
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia.
Fearon KC; Barber MD; Falconer JS; McMillan DC; Ross JA; Preston T
World J Surg; 1999 Jun; 23(6):584-8. PubMed ID: 10227928
[TBL] [Abstract][Full Text] [Related]
29. Muscle wasting.
Childs SG
Orthop Nurs; 2003; 22(4):251-7; quiz 258-9. PubMed ID: 12961968
[TBL] [Abstract][Full Text] [Related]
30. Muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Adv Gerontol; 2006; 18():39-54. PubMed ID: 16676797
[TBL] [Abstract][Full Text] [Related]
31. TNF-α and cancer cachexia: Molecular insights and clinical implications.
Patel HJ; Patel BM
Life Sci; 2017 Feb; 170():56-63. PubMed ID: 27919820
[TBL] [Abstract][Full Text] [Related]
32. Metabolic Alterations in a Slow-Paced Model of Pancreatic Cancer-Induced Wasting.
Wyart E; Reano S; Hsu MY; Longo DL; Li M; Hirsch E; Filigheddu N; Ghigo A; Riganti C; Porporato PE
Oxid Med Cell Longev; 2018; 2018():6419805. PubMed ID: 29682162
[TBL] [Abstract][Full Text] [Related]
33. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
34. Muscle wasting in cancer.
Johns N; Stephens NA; Fearon KC
Int J Biochem Cell Biol; 2013 Oct; 45(10):2215-29. PubMed ID: 23770121
[TBL] [Abstract][Full Text] [Related]
35. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
[TBL] [Abstract][Full Text] [Related]
37. [Nutritional Support for Patients with Pancreatic Cancer].
Jung MK
Korean J Gastroenterol; 2019 Aug; 74(2):87-94. PubMed ID: 31438660
[TBL] [Abstract][Full Text] [Related]
38. Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies.
Gallagher IJ; Stephens NA; MacDonald AJ; Skipworth RJ; Husi H; Greig CA; Ross JA; Timmons JA; Fearon KC
Clin Cancer Res; 2012 May; 18(10):2817-27. PubMed ID: 22452944
[TBL] [Abstract][Full Text] [Related]
39. Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia.
Markov SD; Gonzalez D; Mehla K
Curr Protoc Pharmacol; 2020 Dec; 91(1):e80. PubMed ID: 33264501
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia.
Melstrom LG; Melstrom KA; Ding XZ; Adrian TE
Histol Histopathol; 2007 Jul; 22(7):805-14. PubMed ID: 17455154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
